Andrzej Milanowski

Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study

Harvey L. Levy, Andrzej Milanowski, Anupam Chakrapani et al. · The Lancet · 2007 · 307 citations

Sapropterin Dihydrochloride, Renal Function, Chronic Kidney Disease +6

Efficacy of Sapropterin Dihydrochloride in Increasing Phenylalanine Tolerance in Children with Phenylketonuria: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study

Friedrich K. Trefz, Barbara K. Burton, Nicola Longo et al. · The Journal of Pediatrics · 2009 · 190 citations

Sapropterin Dihydrochloride, Medicine, Inherited Metabolic Disease +6

The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6<i>R</i>‐tetrahydrobiopterin): a phase II, multicentre, open‐label, screening study

Barbara K. Burton, Dorothy K. Grange, Andrzej Milanowski et al. · Journal of Inherited Metabolic Disease · 2007 · 168 citations

Quality of life in noncompliant adults with phenylketonuria after resumption of the diet

Mirosław Bik-Multanowski, Bożena Didycz, Renata Mozrzymas et al. · Journal of Inherited Metabolic Disease · 2008 · 93 citations

Early Decline of Pancreatic Function in Cystic Fibrosis Patients with Class 1 or 2 CFTR Mutations

Jarosław Walkowiak, Dorota Sands, Anna Nowakowska et al. · Journal of Pediatric Gastroenterology and Nutrition · 2005 · 74 citations